Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 2Withdrawn 1Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Observational 1Interventional 1

Sponsor

Cancer Type

Gastrointestinal 7Tumor-Agnostic 4Genitourinary 4Thoracic 3Head & Neck 3Breast 3NET 2Lymphoid 2Gynecologic 2Endocrine 2CNS 2Other hematologic neoplasm 1

Conditions

Uterine Cervical Neoplasms 1Hypoxia 1Endometrial Neoplasms 1

Interventions

Paclitaxel 79Cisplatin 72Carboplatin 72Bevacizumab 29Radiotherapy 27Brachytherapy 23Hyperthermic Intraperitoneal Chemotherapy 20Drug Therapy 20olaparib 19Gemcitabine 17niraparib 16apatinib 16pembrolizumab 15Surgical Procedures, Operative 15liposomal doxorubicin 12Cyclophosphamide 12Surveys and Questionnaires 11camrelizumab 10Taxes 10Neoadjuvant Therapy 10fludarabine 9anlotinib 9Etoposide 9Blood Specimen Collection 9Topotecan 8Docetaxel 8Sentinel Lymph Node Biopsy 7Platinum 7Injections 7Cytoreduction Surgical Procedures 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Unknown × Positron Emission Tomography Computed Tomography × Gynecologic × Clear all
NCT06353061 2025-01-14

Chemoradiotherapy With or Without Metformin in Locally Advanced Cervical Cancer

Peking Union Medical College Hospital

Phase 2 Unknown
51 enrolled
Gynecologic

Hypoxia, Uterine Cervical Neoplasms

NCT03570866 2021-09-30

ENCA-1

Università degli Studi dell'Insubria

Unknown
40 enrolled
Gynecologic

Endometrial Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡